Home Vivacitas

Vivacitas

In operation
-
Chemotherapy Drug Developer
Basic
Enterprise Profile

Basic Information

Vivacitas, co-founded by Dr. Rubinfeld in 2015, is committed to creating new treatment options and improving the lives of cancer patients with solid tumors worldwide. Currently, Vivacitas is targeting the most aggressive cancers by developing new chemotherapy drugs and bringing them to market.
Vivacitas Oncology, Inc.
CaliforniaCity,California,United States of America
15~50 people
January 01, 2015
--

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Concept
Tumor Therapeutic Products
Application Scenarios
Chemical Drug Innovative Drugs Prescription Drug